We designed and synthesized a series of compounds with a 3,5-disubstituted pyridine moiety and evaluated them against
No takes yet. Share an insight, caveat, or question.
Sangu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: